Inteum Company
Links
seedsprint
Visible Legacy
RSS
News & Resources
Inteum Company News
Inteum Library
Subscribe
Search Results - jerry+nadler
2
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
Creation and Use of 12-LO inhibitors (4-((2-hydroxy-3-methoxybenzyl)amino)benzenesulfonamide derivatives) for the Treatment of Diabetes and Large Platelet-Derived Clots
This technology includes the discovery and use of novel selective 12-LO (lipoxygenase) inhibitors, 4-((2-hydroxy-3-methoxybenzyl)amino)benzenesulfonamide derivatives, for attenuating large clots and for the treatment of Type 1/2 diabetes. A 12-LO inhibitor could be a potent intracellular approach to block platelets from forming large clots in response...
Published: 10/28/2024
|
Inventor(s):
Ajit Jadhav
,
Anton Simeonov
,
Adam Yasgar
,
Diane Luci
,
Michael Holinstat
,
Theodore Holman
,
Jerry Nadler
,
David Taylor-Fishwick
,
David Maloney
Keywords(s):
12-Lipoxygenase.
,
4-2-hydroxy-3-methoxybenzylaminobenzenesulfon
,
Derivatives
,
Discovery
,
Human
,
Inhibitors
,
Listed LPM Nguyen-Antczak as of 4/15/2015
,
Post LPM Assignment Set 20150420
,
POTENT
,
Pre LPM working set 20150418
,
SELECTIVE
,
VDXXXX
,
VFXXXX
,
WKXXXX
,
XEXXXX
Category(s):
TherapeuticArea > Cardiology
,
TherapeuticArea > Endocrinology
,
Application > Therapeutics
Selective 12-Human Lipoxygenase Inhibitors for the Treatment of Diabetes and Clotting
This invention discloses small molecule inhibitors of human 12-lipoxygenase (12-hLO). 12-lipoxygenase expression, activation, and lipid metabolites have been implicated in type 1 and type 2 diabetes, cardiovascular disease, hypertension, Alzheimer’s, and Parkinson’s disease. The development of 12-hLO inhibitors may be a potent intracellular approach...
Published: 10/28/2024
|
Inventor(s):
Jerry Nadler
,
Michael Holinstat
,
Anton Simeonov
,
Ajit Jadhav
,
Theodore Holman
,
David Maloney
Keywords(s):
12-human
,
Cardiovascular
,
CAUSED
,
Clot
,
DIABETES
,
Discovery
,
Disease
,
Formation
,
IA1AXX
,
IA1XXX
,
IAXXXX
,
Inhibitors
,
IXXXXX
,
LIPOXYGENASE
,
Platelet-mediated
,
Prevention
,
SELECTIVE
,
treatment
Category(s):
Collaboration Sought > Licensing
,
Application > Research Materials
,
TherapeuticArea > Cardiology
,
Application > Therapeutics
,
Application > Diagnostics